Lung cancer

(1)

Fakultas Kedokteran Universitas Andalas

40 DAFTAR PUSTAKA

1. Hudoyo A, Wibawanto A, Lutfi A, Rima A, Putra AC, Ratnawati A. Kanker paru. 2017;7–18.

2. Siddiqui F, Vaqar S, Siddiqui AH. Lung cancer. Vol. 1, Cambridge Handbook of Psychology, Health and Medicine, Second Edition. StatPearls Publishing; 2021. 605–6 p.

3. WHO. Cancer [Internet]. 2022 [cited 2022 Feb 28]. Available from:

https://www.who.int/news-room/fact-sheets/detail/cancer 4. The Global Cancer Observatory. Global cancer statistics. 2020.

5. Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Contemp Oncol. 2021;25:45.

6. Dewi A, Thabrany H, Satrya A, Chairunnisa G, Rifqi P, Fattah A. Kanker paru, kanker paling mematikan di Indonesia : apa saja yang telah kita atasi dan apa yang bisa kita lakukan. 2021;1:6.

7. Kloecker Goetz, Arnold Susanne, Fraig Mostafa, Perez Cesar. Lung cancer standards of care. Vol. 1. McGraw Hill; 2020. 148 p.

8. Lemjabbar-Alaoui H, Hassan O, Yang YW, Buchanan P. Lung cancer:

biology and treatment options. 2015;1:2–3.

9. Sibuea AA. Karakteristik pasien kanker paru jenis karsinoma bukan sel kecil pada wanita di RSUP. H Adam Malik Medan periode 2012-2015 [Skripsi].

Universitas Sumatera Utara; 2017.

10. Er Services. The lungs | anatomy and physiology II. 2016.

11. Chaudhry R, Bordoni B. Anatomy, thorax, lungs. StatPearls. StatPearls Publishing; 2021.

12. Tate P. Principles of anatomy and physiology. Vol. 2, Seeley. McGraw Hill;

2012. 606–16 p.

13. Betts JG, Desaix P, Johnson E (Edward W), Johnson JE, Korol O, Kruse D.

Anatomy & physiology. Vol. 1. OpenStax College; 2013. 1410 p.

14. Mescher AL, Junqueira LCU, Preceded by: Mescher AL. Junqueira’s basic histology : text and atlas. Vol. 15. McGraw Hill; 2018. 354–68 p.

15. Ovalle WK, Nahirney PC, Netter FH. Netter’s essential histology : with correlated histopathology. Vol. 3. Elsevier; 2020. 508 p.

16. Mitchell RN, Henderson LJ. Pocket companion to robbins and cotran pathologic basis of disease. Vol. 9. Elsevier; 2016. 692 p.

17. Schabath MB, Cote ML. Cancer progress and priorities: lung cancer. Cancer Epidemiology, Biomarkers & Prevention. 2019;28:1563–79.

18. Kanwal M, Ding XJ, Cao Y. Familial risk for lung cancer. Oncol Lett. 2017 Feb 1;13:535.

(2)

41 19. dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology,

etiology, and prevention. Clin Chest Med. 2011 Dec;32(1):605–44.

20. The American Cancer Society Medical and Editorial Content Team. Lung cancer risk factors [Internet]. 2019 [cited 2022 Apr 2]. Available from:

https://www.cancer.org/cancer/lung-cancer/causes-risks-prevention/risk- factors.html

21. Loda M, Mucci LA, Mieke MLM, Hemelrijck V, Cotter MB. Pathology and epidemiology of cancer. Vol. 1. Springer; 2017. 347 p.

22. Regional Office for Europe WHO. World cancer report : cancer research for cancer development. Vol. 1. IARC; 2020. 23 p.

23. Suraya A, Nowak D, Sulistomo AW, Icksan AG, Syahruddin E, Berger U.

Asbestos related lung cancer: a hospital based case control study in Indonesia. Int J Environ Res Public Health. 2020;17(1):2.

24. Gaskin J, Coyle D, Whyte J, Krewksi D. Global estimate of lung cancer mortality attributable to residential radon. Environ Health Perspect.

2018;126:1.

25. de Groot PM, Wu CC, Carter BW, Munden RF. The epidemiology of lung cancer. Transl Lung Cancer Res. 2018 Jun 1;7(1):220.

26. Syahruddin E., Anwar Jusuf, Agung Wibawanto. Kanker paru : jenis karsinoma bukan sel kecil : pedoman nasional untuk diagnosis &

penatalaksanaan di Indonesia. UI Press; 2018. 8–15 p.

27. Rosen ST, Reckamp Editor KL. Lung cancer treatment and research. Vol.

170. Springer; 2016. 25–8 p.

28. Nicholson AG, Tsao MS, Beasley MB, Borczuk AC, Brambilla E, Cooper WA, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. Vol. 17, Journal of Thoracic Oncology. Elsevier Inc.; 2022. p.

362–87.

29. Cheng L, Bostwick DG. Essentials of anatomic pathology. Essentials of Anatomic Pathology: Fourth Edition. 2016 Feb 13;4:1–2109.

30. Chiesa S, Majori M, Nizzoli R, Guazzi A, Anghinolfi M, Chetta A.

Transbronchial Needle Aspiration (TBNA) in the diagnosis and staging of lung cancer in a large cohort of patients. European Respiratory Journal . 2011. p. 243.

31. Suster Saul, Moran Cesar. Biopsy interpretation of the lung. Vol. 1. 2012.

427 p.

32. Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, et al. The 2015 world health organization classification of lung tumors:

impact of genetic, clinical and radiologic advances since the 2004 classification. Journal of Thoracic Oncology. 2015 Sep 26;10:1243–60.

33. Sattar HA. Fundamentals of pathology. Vol. 1. Pathoma LLC; 2019. 95–8 p.

34. Travis WD. Lung cancer pathology: current concepts. Vol. 41, Clinics in Chest Medicine. W.B. Saunders; 2020. 67–85 p.

(3)

42 35. Kadota K, Nitadori JI, Woo KM, Sima CS, Finley DJ, Travis WD.

Comprehensive pathological analyses in lung squamous cell carcinoma:

single cell invasion, nuclear diameter and tumor budding are independent prognostic factors for worse outcomes. J Thorac Oncol. 2014;9:1126.

36. Popper H. Pathology of lung disease. Vol. 2, Pathology of Lung Disease.

Springer International Publishing; 2021. 353 p.

37. de Sá VK, Carvalho L, Gomes A, Alarcão A, Silva MR, Couceiro P. Role of the extracellular matrix in variations of invasive pathways in lung cancers.

Brazilian Journal of Medical and Biological Research. 2013 Jan;46:21–31.

38. Marchevsky AM. Pathologic classification of lung malignancies and special pathologic procedures. Medical Management of the Thoracic Surgery Patient. 2010;1:213–37.

39. Ferrara MG, Stefani A, Simbolo M, Pilotto S, Martini M, Lococo F. Large cell neuro-endocrine carcinoma of the lung: current treatment options and potential future opportunities. Front Oncol. 2021 Apr 15;11.

40. Kalyani K, Rao P, Chiranjeevi K. Changing trends in histopathology of lung cancer in a tobacco prevalent area of south india. IP Indian Journal of Immunology and Respiratory Medicine. 2020 Dec 28;3(2):64–7.

41. Putra DH, Wulandari L, Mustokoweni S. Profil penderita kanker paru karsinoma bukan sel kecil (kpkbsk) di rsud dr. soetomo. UXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga. 2016;8(1):31–3.

42. Lewis DR, Check DP, Caporaso NE, Travis WD, Devesa SS. US lung cancer trends by histologic type. Cancer. 2014 Sep 1;120(18):2883–92.

43. Doresi S, Saragih S, Soeroso NN, Syarani F, Zalukhu F, Lubis ND. Akurasi diagnostik transthoracic needle aspiration dengan tuntunan ultrasonografi toraks pada kanker paru. J Respir Indo. 2016;36(4).

44. Li D, Shi J, Dong X, Liang D, Jin J, He Y. Epidemiological characteristics and risk factors of lung adenocarcinoma: A retrospective observational study from North China. Front Oncol. 2022 Aug 5;12:3–4.

45. Chairudin MR, Anang Marhana I, Erawati D. Profil pasien kanker paru primer yang dirawat inap dan rawat jalan di rumah sakit umum daerah dr soetomo surabaya. Jurnal Respirasi. 2019;5(3).

46. Tatun R, Icksan AG, Syahruddin E, Kekalih A. Gambaran ct scan toraks sesuai dengan jenis sitologi/histologi pada pasien kanker paru yang merokok.

eJournal Kedokteran Indonesia. 2015;3(3):178.

47. Rizki Ananda R, Ermayanti S. Hubungan staging kanker paru dengan skala nyeri pada pasien kanker paru yang dirawat di bagian paru rsup dr m djamil padang. Jurnal Kesehatan Andalas. 2018;7(3).

48. Chandra Putra A, Nurwidya F, Andarini S, Zaini J, Syahruddin E, Hudoyo A, et al. Masalah kanker paru pada lanjut usia. RSUP Persahabatan, Jakarta.

2015;834.

(4)

43 49. Purnamawati P, Tandrian C, Sumbayak EM, Kertadjaja W. Analisis kejadian kanker paru primer di Indonesia pada tahun 2014-2019. Jurnal Kedokteran Meditek. 2021 Jun 25;27(2):164–72.

50. Kartika Nur Aisah S, Bakhriansyah M. Profil penderita kanker paru primer di rsud ulin banjarmasin tahun 2006-2011. Jurnal Berkala Kedokteran.

2013;9(2):170.

51. Juliandi. Pengaruh tingkat kecemasan pasien carsinoma paru dalam menjalani tindakan kemoterapi di ruang kemoterapi rsud dr. zoelham binjai tahun 2016. Jurnal Ilmiah PANMED. 2017;11(3):167–71.

52. Sivabalan Logawathi S, Causa Trisna Mariedina. Characteristics of lung cancer patients in haji adam malik general hospital medan in 2016-2018.

Journal of Endocrinology, Tropical Medicine, and Infectiouse Disease (JETROMI). 2020 Feb 3;2(1):31–9.

53. Wulandari A, Monalisa S, Zaini J. Analisis biaya kemoterapi lini pertama pada pasien kanker paru di rumah sakit persahabatan jakarta timur periode 2016. Sainstech Farma: Jurnal Ilmu Kefarmasian. 2019;12(2):186–7.

54. Afifah F. Hubungan jenis kelamin dengan riwayat merokok dengan jenis sel kanker paru pada pasien kanker paru yang dirawat di bangsal paru rsup dr.

m. djamil padang tahun 2017-2018 [Skripsi]. Universitas Andalas; 2019.

55. Ernawati Y, Ermayanti S, Herman D. Faktor risiko kanker paru pada perempuan yang dirawat di bagian paru rsup dr. m. djamil padang dan rsud solok. Jurnal Kesehatan Andalas. 2019;8:5–6.

56. What Are the Risk Factors for Lung Cancer? | CDC [Internet]. [cited 2023

Jan 23]. Available from:

https://www.cdc.gov/cancer/lung/basic_info/risk_factors.htm

57. Aini SR, Wulandari L, Andajani S. Lung cancer patients profile in dr soetomo general hospital surabaya 2016 - 2017: newest report. JUXTA:

Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga. 2019 Jan 30;10(1):44.

58. Arumsari D, Martini S, Artanti KD, Widati S. The description of smoking degree based on brinkman index in patients with lung cancer. Jurnal Berkala Epidemiologi. 2019;7(3):249–56.

59. Ahyati SN, Kustiyah Oktaviyanti I, Yuliana I. Hubungan jenis kelamin dan riwayat merokok dengan mutasi gen egfr kanker paru tipe adenokarsinoma.

Homeostasis. 2019;2(1):3–4.

60. Khasanah NA, Oktaviyanti IK, Yuliana I. Hubungan riwayat merokok dan tempat tinggal dengan gambaran sitopatologi kanker paru.

Homeostasis: Jurnal Mahasiswa Pendidikan Kedokteran. 2019;2(1):93–8.

61. Angriawan M, Angeline R, Angka RN. Pengaruh rokok terhadap gambaran histopatologi kanker paru. Jurnal Kedokteran Meditek. 2022 Sep 1;28(3):372–81.